US Stock Insider Trading | InspireMD disclosed 1 insider transaction on February 23

K-LinePoet · 2026-03-02T05:29:27+00:00

InspireMD disclosed insider trading on February 23, 2026, with director Stuka Paul purchasing 2,710 shares on December 9, 2025. The company focuses on medical devices, developing MicroNet stent technology to improve blood flow.

K-LinePoet

2026-03-02 05:29:27

Abstract generation in progress

On February 23, 2026, InspireMD (NSPR) disclosed one insider transaction. Director Stuka Paul purchased 2,710 shares on December 9, 2025.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 23, 2026	Director	Stuka Paul	December 9, 2025	Buy	2,710	1.81	4,905.10
February 2, 2026	Executive	Gleason Shane Thomas	January 29, 2026	Sell	5,000	1.65	8,250.00
February 2, 2026	Executive	Gleason Shane Thomas	February 2, 2026	Sell	2,000	1.60	3,208.00
February 2, 2026	Executive	Gleason Shane Thomas	January 15, 2026	Sell	2,909	1.58	4,593.31
February 2, 2026	Executive	Gleason Shane Thomas	January 21, 2026	Sell	17,600	1.62	28,600.00
February 2, 2026	Executive	Gleason Shane Thomas	January 22, 2026	Sell	8,411	1.57	13,200.00
February 2, 2026	Executive	Gleason Shane Thomas	January 16, 2026	Sell	2,250	1.61	3,627.00
February 2, 2026	Executive	Gleason Shane Thomas	January 20, 2026	Sell	2,955	1.59	4,710.27
February 2, 2026	Executive	Gleason Shane Thomas	January 30, 2026	Sell	2,900	1.63	4,729.90
February 2, 2026	Executive	Gleason Shane Thomas	January 27, 2026	Sell	4,781	1.66	7,955.58

[Company Profile]

InspireMD, Inc. was incorporated on February 29, 2008, in Delaware. The company was originally called Saguaro Resources Corporation, involved in acquiring, exploring, and developing natural resources. On March 28, 2011, the company changed its name from “Cactus Resources Limited” to “InspireMD, Inc.” The company is a medical device firm focused on developing and commercializing its proprietary MicroNet platform technology for treating complex vascular and coronary artery diseases. The stent is a expandable “scaffold-like” device, typically made of metal, inserted into arteries to expand the internal passage and improve blood flow. MicroNet is a micron-sized mesh sleeve wrapped around the stent, providing embolic protection during stent implantation.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes